Trial intelligence / Profile preview

Chantix for smoking cessation (A3051055)

NCT00371813Phase 3Completed

Sponsor
Pfizer
Start
Sep 2006
Countries
3
01

Overview

A Phase 3 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by Pfizer. Started Sep 2006; status: completed.

02

Drugs

varenicline
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00371813.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00371813.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call